In vivo evidence suggesting a role for purine-catabolizing enzymes in the pathogenesis of cisplatin-induced nephrotoxicity in rats and effect of erdosteine against this toxicity

Cell Biochemistry and Function

Volumn 22, Issue 3, 2004, Pages 157-162

  Söǧüt, Sadik ^a   Kotuk, Mahir ^a   Yilmaz, H Ramazan ^b   Ulu, Ramazan ^a   Özyurt, Hüseyin ^c   Yildirim, Zeki ^a,d  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^c GAZIOSMANPASA UNIVERSITY   (Turkey)

^d INONU UNIVERSITY   (Turkey)

Author keywords

Adenosine deaminase; Cisplatin; Erdosteine; Nephrotoxicity; Xanthine oxidase

Indexed keywords

ADENOSINE DEAMINASE; CISPLATIN; CREATININE; ERDOSTEINE; NITROGEN; PURINE; UREA; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; IN VIVO STUDY; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE METABOLISM; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; RAT; UREA NITROGEN BLOOD LEVEL;

ADENOSINE DEAMINASE; ANIMALS; CISPLATIN; FEMALE; KIDNEY FAILURE, ACUTE; PURINES; RATS; RATS, WISTAR; THIOGLYCOLATES; THIOPHENES; XANTHINE OXIDASE;

EID: 1842567627     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1069     Document Type: Article

References (33)

1. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 1999; 3: 971-997.
2. Kruidering M, Van de Water B, de Heer E, Mulder GJ, Nagelkerke JF. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 1997; 280: 638-649.
3. Ozyurt H, Irmak MK, Akyol O, Sogut S. Caffeic acid phenethyl ester changes the indices of oxidative stress in serum of rats with renal ischemia-reperfusion injury. Cell Biochem Funct 2001; 19: 259-263.
4. Lehninger AL, Nelson DL, Cox MM. Enzymes. In Principles of Biochemistry (2nd edn). Worth Publishers: NY, USA, 1993; 198-237.
5. Mansour MA, Mostafa AM, Nagi MN, Khattab MM, Al-Shabanah OA. Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats. Comp Biochem Physiol C Toxicol Pharmacol 2002; 132: 123-128.
6. Saad SY, Al-Rikabi AC. Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy 2002; 48: 42-48.
7. Durak I, Ozbek H, Karaayvaz M, Ozturk HS. Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug Chem Toxicol 2002; 25: 1-8.
8. Hara M, Yoshida M, Nishijima H, et al. Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats. J Pineal Res 2001; 30: 129-138.
9. Somani SM, Husain K, Whitworth C, Trammell GL, Malafa M, Rybak LP. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol 2000; 86: 234-241.
10. Dechant KL, Noble S. Erdosteine. Drugs 1996; 52: 875-881.
11. Braga PC, Dal Sasso M, Zuccotti T. Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts. Arzneimittelforschung 2000; 50: 739-746.
12. Biagi GL, Fregnan GB, Gazzani G, Vandoni G. Erdosteine protection from cigarette smoke-induced loss of alpha 1-antitrypsin activity in rat lungs. Int J Clin Pharmacol Ther Toxicol 1989; 27: 235-237.
13. Inglesi M, Nicola M, Fregnan GB, Bradamante S, Pagani G. Synthesis and free radical scavenging properties of the enantiomers of erdosteine. Farmaco 1994; 40: 703-708.
14. Vagliasindi M, Fregman GB. Erdosteine protection against cigarette smoking-induced functional antiprotease deficiency in human bronchiolo-alveolar structures. Int J Clin Farmacol Toxicol 1989; 27: 238-241.
15. Yildirim Z, Sogut S, Odaci E, et al. Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res 2003; 47: 149-156.
16. Zhang JG, Viale M, Esposito M, Lindup WE. Tiopronin protects against the nephrotoxicity of cisplatin in the rat. Hum Exp Toxicol 1999; 18: 713-717.
17. Lowry O, Rosebrough N, Farr L, Randall R. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951; 183: 265-275.
18. Prajda N, Weber G. Malignant transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett 1975; 59: 245-249.
19. Giusti G. Adenosine deaminase. In Methods of Enzymatic Analysis, Bergmeyer MV (ed.). Academic Press: New York, 1974; 1092-1098.
20. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, Gutteridge JM. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med 1997; 155: 479-484.
21. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-163.
22. Granger DN, Hollwarth ME, Parks DA. Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol Scand 1986; 548(Suppl.): 47-63.
23. Grum CM, Ragsdale RA, Ketai LH, Simon RH. Plasma xanthine oxidase activity in patients with adult respiratory distress syndrome. J Crit Care 1987; 2: 22-26.
24. Ilhan A, Koltuksuz U, Ozen S, Efkan U, Ciralik H, Akyol O. The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur J Cardiothor Surg 1999; 16: 458-463.
25. Irmak MK, Koltuksuz U, Kutlu NO, et al. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparision with α-tocopherol in rat kidneys. Urol Res 2001; 29: 190-193.
26. Yildirim Z, Hasanoglu HC, Akyol O, Gokirmak M, Koksal N. Serum adenosine deaminase activities in lung cancer and mesothelioma. Clin Biochem 1999; 32: 283-285.
27. Akyol O, Gokbulut I, Koksal N, Akin H, Ozyurt H, Yildirim Z. The activities of purine catabolizing enzymes in plasma and bronchial washing fluid in patients with lung cancer and pneumonia. Clin Biochem 2001; 34: 251-254.
28. Xia Y, Zweier JL. Substrate control of free radical generation from xanthine oxidase in the postischemic hart. J Biol Chem 1995; 270: 18797-18803.
29. Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 2001; 12: 2683-90.
30. Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M. L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 2002; 405: 55.
31. Abd-Elfattah AS, Jessen ME, Lekven J, Wechsler AS. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury. Mol Cell Biochem 1998; 180: 179-91.
32. Racz I, Tory K, Gallyas F, Jr, et al. BGP-15 - A novel poly-(ADP-ribose) polymerase inhibitor - Protects against nephrotoxicity of cisplatin without compromising its antitumor activity. Biochem Pharmacol 2002; 63: 1099-1111.
33. Camargo SM, Francescato HD, Lavrador MA, Bianchi ML. Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats. Biol Trace Elem Res 2001; 83: 251-262.